S N Mehta1, T R Nansel2, L K Volkening1, D A Butler1, D L Haynie2, L M B Laffel1. 1. Pediatric, Adolescent and Young Adult Section, Genetics and Epidemiology Section, Joslin Diabetes Center, Boston, MA, USA. 2. Health Behavior Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
Abstract
AIMS: To evaluate the psychometric properties of the Diabetes Management Questionnaire, a brief, self-report measure of adherence to contemporary diabetes management for young people with Type 1 diabetes and their caregivers. METHODS: A total of 273 parent-child dyads completed parallel versions of the Diabetes Management Questionnaire. Eligible children (aged 8-18 years) had Type 1 diabetes for ≥1 year. A multidisciplinary team designed the Diabetes Management Questionnaire as a brief, self-administered measure of adherence to Type 1 diabetes management over the preceding month; higher scores reflect greater adherence. Psychometrics were evaluated for the entire sample and according to age of the child. RESULTS: The children (49% female) had a mean ± sd (range) age 13.3 ± 2.9 (8-18) years and their mean ± sd HbA1c was 71 ± 15 mmol/mol (8.6 ± 1.4%). Internal consistency was good for parents (α = 0.83) and children (α = 0.79). Test-retest reliability was excellent for parents (intraclass correlation coefficient =0.83) and good for children (intraclass correlation coefficient = 0.65). Parent and child scores had moderate agreement (intraclass correlation coefficient = 0.54). Diabetes Management Questionnaire scores were inversely associated with HbA1c (parents: r = -0.41, P < 0.0001; children: r = -0.27, P < 0.0001). Psychometrics were stronger in the children aged ≥13 years compared with those aged < 13 years, but were acceptable in both age groups. Mean ± sd Diabetes Management Questionnaire scores were higher among children who were receiving insulin pump therapy (n = 181) than in children receiving multiple daily injections (n = 92) according to parent (75.9 ± 11.8 vs. 70.5 ± 15.5; P = 0.004) and child report (72.2 ± 12.1 vs. 67.6 ± 13.9; P = 0.006). CONCLUSIONS: The Diabetes Management Questionnaire is a brief, valid self-report measure of adherence to contemporary diabetes self-management for people aged 8-18 years who are receiving either multiple daily injections or insulin pump therapy.
AIMS: To evaluate the psychometric properties of the Diabetes Management Questionnaire, a brief, self-report measure of adherence to contemporary diabetes management for young people with Type 1 diabetes and their caregivers. METHODS: A total of 273 parent-child dyads completed parallel versions of the Diabetes Management Questionnaire. Eligible children (aged 8-18 years) had Type 1 diabetes for ≥1 year. A multidisciplinary team designed the Diabetes Management Questionnaire as a brief, self-administered measure of adherence to Type 1 diabetes management over the preceding month; higher scores reflect greater adherence. Psychometrics were evaluated for the entire sample and according to age of the child. RESULTS: The children (49% female) had a mean ± sd (range) age 13.3 ± 2.9 (8-18) years and their mean ± sd HbA1c was 71 ± 15 mmol/mol (8.6 ± 1.4%). Internal consistency was good for parents (α = 0.83) and children (α = 0.79). Test-retest reliability was excellent for parents (intraclass correlation coefficient =0.83) and good for children (intraclass correlation coefficient = 0.65). Parent and child scores had moderate agreement (intraclass correlation coefficient = 0.54). Diabetes Management Questionnaire scores were inversely associated with HbA1c (parents: r = -0.41, P < 0.0001; children: r = -0.27, P < 0.0001). Psychometrics were stronger in the children aged ≥13 years compared with those aged < 13 years, but were acceptable in both age groups. Mean ± sd Diabetes Management Questionnaire scores were higher among children who were receiving insulin pump therapy (n = 181) than in children receiving multiple daily injections (n = 92) according to parent (75.9 ± 11.8 vs. 70.5 ± 15.5; P = 0.004) and child report (72.2 ± 12.1 vs. 67.6 ± 13.9; P = 0.006). CONCLUSIONS: The Diabetes Management Questionnaire is a brief, valid self-report measure of adherence to contemporary diabetes self-management for people aged 8-18 years who are receiving either multiple daily injections or insulin pump therapy.
Authors: T Danne; H B Mortensen; P Hougaard; H Lynggaard; H J Aanstoot; F Chiarelli; D Daneman; H Dorchy; P Garandeau; S A Greene; H Hoey; R W Holl; E A Kaprio; M Kocova; P Martul; N Matsuura; K J Robertson; E J Schoenle; O Søvik; P G Swift; R M Tsou; M Vanelli; J Aman Journal: Diabetes Care Date: 2001-08 Impact factor: 19.112
Authors: M A Harris; T Wysocki; M Sadler; K Wilkinson; L M Harvey; L M Buckloh; N Mauras; N H White Journal: Diabetes Care Date: 2000-09 Impact factor: 19.112
Authors: Korey K Hood; Deborah A Butler; Lisa K Volkening; Barbara J Anderson; Lori M B Laffel Journal: Diabetes Care Date: 2004-11 Impact factor: 19.112
Authors: Suzanne B Johnson; Janet Silverstein; Arlan Rosenbloom; Randy Carter; Walter Cunningham Journal: Health Psychol Date: 1986 Impact factor: 4.267
Authors: Persis V Commissariat; Lisa K Volkening; Zijing Guo; Jessica L ElBach; Deborah A Butler; Lori M Laffel Journal: Pediatr Diabetes Date: 2017-04-19 Impact factor: 4.866
Authors: Lisa E Rasbach; Lisa K Volkening; Jessica T Markowitz; Deborah A Butler; Michelle L Katz; Lori M B Laffel Journal: Diabetes Technol Ther Date: 2015-02-19 Impact factor: 6.118
Authors: Miriam H Eisenberg Colman; Virginia M Quick; Leah M Lipsky; Katherine W Dempster; Aiyi Liu; Lori M B Laffel; Sanjeev N Mehta; Tonja R Nansel Journal: Diabetes Care Date: 2018-01-25 Impact factor: 19.112
Authors: Mark A Clements; Stephen A DeLurgio; David D Williams; Sana Habib; Kelsee Halpin; Susana R Patton Journal: Diabetes Technol Ther Date: 2016-06 Impact factor: 6.118
Authors: Kara R Harrington; Amit Shapira; Lisa K Volkening; Deborah A Butler; Barbara J Anderson; Rachel M Wasserman; Lori M Laffel Journal: J Diabetes Complications Date: 2021-01-06 Impact factor: 2.852